Rational selection of biomarker driven therapies for gynecologic cancers: The more we know, the more we know we don’t know

gan Liu, Joyce, Westin, Shannon N.
Cyhoeddwyd yn Gynecol Oncol (2016)

The European Society of Gynecologic Oncology (ESGO) 19(th) Biannual Meeting: Overview and summary of selected topics

gan Westin, Shannon N., Randall, Leslie
Cyhoeddwyd yn Gynecol Oncol (2016)

Personalized therapy in endometrial cancer: Challenges and opportunities

gan Westin, Shannon N, Broaddus, Russell R
Cyhoeddwyd 2012

Individualized Medicine in Ovarian Cancer: Are We There Yet?

gan Westin, Shannon N., Coleman, Robert L.
Cyhoeddwyd yn Gynecol Oncol (2017)

Application of Immunohistochemistry and Molecular Diagnostics to Clinically Relevant Problems in Endometrial Cancer Bojana Djordjevic, Shannon Westin, Russell R. Broaddus

gan Djordjevic, Bojana, Westin, Shannon, Broaddus, Russell R.
Cyhoeddwyd 2012

Status epilepticus associated with platinum chemotherapy in a patient with cervical cancer: a case report

gan Holman, Laura L., Ren, Yulan, Westin, Shannon N.
Cyhoeddwyd yn BMC Cancer (2015)

Pushing the envelope: expanding fertility sparing treatment of endometrial cancer

gan Stewart, Katherine Ikard, Yates, Melinda S., Westin, Shannon N.
Cyhoeddwyd yn J Gynecol Oncol (2020)

Movement of Poly-ADP Ribose (PARP) Inhibition Into Frontline Treatment of Ovarian Cancer

gan Onstad, Michaela, Coleman, Robert L., Westin, Shannon N.
Cyhoeddwyd yn Drugs (2020)

Current and future landscape of PARPi resistance

gan Hinchcliff, Emily, Chelariu-Raicu, Anca, Westin, Shannon N.
Cyhoeddwyd yn Curr Opin Obstet Gynecol (2021)

Using PARP Inhibitors in the Treatment of Patients with Ovarian Cancer

gan Kurnit, Katherine, Coleman, Robert L., Westin, Shannon N.
Cyhoeddwyd yn Curr Treat Options Oncol (2018)

Repurposing the Pap Smear: One Step Closer to Gynecologic Cancer Screening

gan Westin, Shannon N., Mills, Gordon B., Myers, Andrea P.
Cyhoeddwyd 2013

Investigational Agents in Development for the Treatment of Ovarian Cancer

gan Westin, Shannon N., Herzog, Thomas J., Coleman, Robert L.
Cyhoeddwyd 2012

MICROSATELLITE INSTABILITY IN ENDOMETRIAL CANCER: NEW PURPOSE FOR AN OLD TEST

gan Kurnit, Katherine C., Westin, Shannon N., Coleman, Robert L.
Cyhoeddwyd yn Cancer (2019)

Rapidly Changing Landscape of Fallopian Tube Carcinoma

gan Kurnit, Katherine C., Lu, Karen H., Westin, Shannon N.
Cyhoeddwyd yn J Oncol Pract (2019)

Has dose dense chemotherapy met an ICONic end?

gan Hinchcliff, Emily M., Meyer, Larissa A., Westin, Shannon N.
Cyhoeddwyd yn Lancet Oncol (2020)

Early Cervical Neoplasia: Advances in Screening and Treatment Modalities

gan Tierney, Brent, Westin, Shannon N., Schlumbrecht, Matthew P., Ramirez, Pedro T.
Cyhoeddwyd yn Clin Adv Hematol Oncol (2010)

Unusual indolent behavior of leiomyosarcoma of the vagina: Is observation a viable option?

gan Khafagy, Ayatallah M., Prescott, Lauren S., Malpica, Anais, Westin, Shannon N.
Cyhoeddwyd yn Gynecol Oncol Rep (2017)

Rucaparib in ovarian cancer: extending the use of PARP inhibitors in the recurrent disease

gan Dal Molin, Graziela Z, Westin, Shannon N, Coleman, Robert L
Cyhoeddwyd yn Future Oncol (2018)

Progestin Intrauterine Device in an Adolescent With Grade 2 Endometrial Cancer

gan Brown, Alaina J., Westin, Shannon N., Broaddus, Russell R., Schmeler, Kathleen
Cyhoeddwyd 2012

A non-pregnant woman with elevated beta-HCG: A case of para-neoplastic syndrome in ovarian cancer

gan Goldstein, Jennifer, Pandey, Prasamsa, Fleming, Nicole, Westin, Shannon, Piha-Paul, Sarina
Cyhoeddwyd yn Gynecol Oncol Rep (2016)